Bullish Moving Averages
15
Bearish Moving Averages
1
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
640.40Today’s High
663.0052W low
506.8052W High
722.60Open Price
647.40Prev. Close
609.4000Volume
172663.00Value
111281303.50Fundamentals
Market Cap
3412.80
Price to Earnings
48.20
Price to Book Value
6.50
Dividend Yield
0.00
PE to Growth
4.90
Op Revenue TTM
571.88
Net Profit TTM
70.77
Cash From Operating Activity
167.64
Return on Equity %
13.43
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
55.5
Week
46.6
Month
53.3
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
649.28
PIVOT
First Resistance
658.22
Second Resistance
671.93
Third Resistance
680.87
First Support
635.57
Second Support
626.63
Third Support
612.92
Relative Strength Index
54.19
Money Flow Index
65.08
MACD
3.82
MACD Signal
3.11
Average True Range
21.73
Average Directional Index
17.89
Rate of Change (21)
7.17
Rate of Change (125)
-2.64
Commodity Channel Index
42.9
Williams %R
-64.8
BETA
1 Month
0.67
3 Month
0.47
1 Year
0.5
3 Year
0.33
PRICE CHANGE ANALYSIS
↑ 1.13%
1 Week
Low
High
636.6
689.7
↑ 7.17%
1 Month
Low
High
602.1
689.7
↑ 1.11%
3 Months
Low
High
571.4
689.7
↓ -2.16%
6 Months
Low
High
554.1
722.65
↑ 21.02%
1 Year
Low
High
506.8
722.65
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 144.04 | 124.98 | 138.11 | 124.07 | 126.89 | 118.44 | 126.39 | 120.13 | 125.03 | 111.30 | 170.69 | |
| Operating Expenses Qtr | 107.64 | 92.36 | 99.66 | 90.49 | 102.05 | 91.26 | 95.69 | 85.44 | 86.50 | 74.20 | 81.50 | |
| Operating Profit Qtr | 33.59 | 30.53 | 36.63 | 33.12 | 22.77 | 25.91 | 29.54 | 33.80 | 36.83 | 36.00 | 87.24 | |
| EBIDT Qtr Cr | 36.40 | 32.62 | 38.45 | 33.58 | 24.84 | 27.18 | 30.70 | 34.69 | 38.53 | 37.10 | 89.19 | |
| Depreciation Qtr | 10.41 | 10.90 | 9.30 | 8.51 | 9.42 | 9.01 | 8.07 | 7.58 | 8.57 | 7.40 | 6.71 | |
| Net Profit Qtr | 19.23 | 14.89 | 20.29 | 16.73 | 9.93 | 12.63 | 14.30 | 20.12 | 20.35 | 22.60 | 60.56 | |
| Basic EPS Qtr | 3.63 | 2.81 | 3.83 | 3.16 | 1.88 | 2.38 | 2.70 | 3.81 | 3.86 | 4.28 | 11.45 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 531.20 | 491.85 | 568.93 | 486.55 | 410.48 | |
| Operating Expenses Annual Cr | 390.14 | 374.45 | 330.70 | 303.53 | 233.29 | |
| Operating Profit Annual | 133.88 | 112.01 | 230.83 | 170.74 | 167.77 | |
| Operating Profit Margin Annual % | 25.20 | 22.77 | 40.57 | 35.09 | 40.87 | |
| Total Expenses Annual Cr | 432.98 | 410.78 | 361.55 | 325.27 | 254.15 | |
| EBIDT Annual Cr | 141.06 | 117.40 | 238.23 | 183.02 | 177.19 | |
| EBIDT Annual margin % | 26.55 | 23.87 | 41.87 | 37.62 | 43.17 | |
| Depreciation | 39.11 | 34.08 | 28.47 | 21.08 | 19.54 | |
| PAT Before ExtraOrdinary Items Annual Cr | 71.14 | 56.97 | 152.05 | 119.77 | 79.32 | |
| Net Profit Annual | 71.14 | 56.97 | 152.05 | 119.77 | 79.32 | |
| Basic EPS Annual | 13.44 | 10.77 | 28.75 | 22.66 | 15.02 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 513.81 | 521.04 | 520.70 | 445.46 | 378.23 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 30.51 | 17.63 | 16.18 | 19.64 | 13.41 | |
| Total Current Liabilities Annual Cr | 75.96 | 73.20 | 60.29 | 62.69 | 50.75 | |
| Total Capital Plus Liabilities Annual Cr | 620.28 | 611.87 | 597.17 | 527.79 | 442.39 | |
| Fixed Assets Annual | 160.05 | 157.49 | 151.54 | 127.43 | 115.43 | |
| Total Non Current Assets Annual | 374.63 | 376.50 | 366.15 | 345.29 | 328.74 | |
| Total Current Assets Annual | 245.65 | 235.37 | 231.02 | 182.50 | 113.65 | |
| Total Assets Annual | 620.28 | 611.87 | 597.17 | 527.79 | 442.39 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 0.00 | 0.00 | 129.05 | 234.11 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 155.20 | 120.02 | 105.68 | 110.41 | 136.33 | |
| Cash from Investing Activity Annual | -80.28 | -31.65 | -12.32 | -53.19 | 26.84 | |
| Cash from Financing Annual Activity | -83.71 | -87.50 | -86.91 | -57.05 | -162.65 | |
| Net Cash Flow Annual | - | 0.87 | 6.45 | 0.17 | 0.52 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 97.04 | 98.44 | 98.43 | 84.25 | 71.58 | |
| ROE Annual % | 13.84 | 10.93 | 29.20 | 26.88 | 20.97 | |
| ROCE Annual % | 18.72 | 15.46 | 39.07 | 34.81 | 40.25 | |
| Total Debt to Total Equity Annual | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBDIT Annual Margin % | 26.91 | 24.13 | 42.42 | 38.58 | 44.18 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 157.74 | 137.47 | 150.17 | 135.87 | 139.58 | 130.13 | 136.59 | 128.79 | 132.71 | 118.80 | 191.40 | |
| Operating Expenses Qtr | 120.44 | 103.15 | 110.48 | 100.58 | 111.19 | 100.17 | 103.39 | 91.87 | 92.97 | 80.60 | 86.92 | |
| Operating Profit Qtr | 33.81 | 31.59 | 37.52 | 34.31 | 24.69 | 27.86 | 31.58 | 35.92 | 37.59 | 36.80 | 89.29 | |
| EBIDT Qtr Cr | 37.30 | 34.32 | 39.69 | 35.29 | 28.39 | 29.96 | 33.20 | 36.92 | 39.74 | 38.20 | 104.48 | |
| Depreciation Qtr | 13.06 | 13.47 | 10.65 | 9.63 | 10.80 | 10.15 | 9.15 | 8.61 | 9.67 | 8.80 | 8.16 | |
| Net Profit Qtr | 17.78 | 15.35 | 20.34 | 17.30 | 12.60 | 14.72 | 15.43 | 21.73 | 21.24 | 21.50 | 77.73 | |
| Basic EPS Qtr | 3.54 | 2.78 | 3.84 | 3.25 | 2.36 | 1.89 | 3.80 | 4.11 | 4.04 | 4.05 | 14.70 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 581.25 | 535.09 | 618.11 | 507.05 | 440.93 | |
| Operating Expenses Annual Cr | 434.45 | 406.62 | 353.97 | 323.36 | 260.69 | |
| Operating Profit Annual | 137.43 | 120.05 | 234.89 | 171.26 | 173.57 | |
| Operating Profit Margin Annual % | 23.64 | 22.44 | 38.00 | 33.78 | 39.36 | |
| Total Expenses Annual Cr | 485.66 | 447.68 | 390.21 | 354.51 | 294.45 | |
| EBIDT Annual Cr | 146.80 | 128.47 | 264.14 | 183.69 | 180.24 | |
| EBIDT Annual margin % | 25.26 | 24.01 | 42.73 | 36.23 | 40.88 | |
| Depreciation | 47.01 | 38.71 | 33.87 | 30.28 | 31.91 | |
| PAT Before ExtraOrdinary Items Annual Cr | 69.10 | 63.18 | 176.32 | 113.22 | 87.89 | |
| Net Profit Annual | 70.76 | 64.36 | 176.14 | 113.15 | 88.40 | |
| Basic EPS Annual | 13.40 | 12.14 | 33.25 | 21.37 | 16.71 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 526.77 | 534.30 | 526.57 | 427.27 | 366.64 | |
| Minority Interest Liability Annual Cr | 0.86 | 0.92 | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 25.77 | 20.40 | 16.57 | 23.42 | 22.54 | |
| Total Current Liabilities Annual Cr | 90.48 | 77.10 | 64.52 | 95.11 | 81.70 | |
| Total Capital Plus Liabilities Annual Cr | 643.88 | 632.72 | 607.66 | 545.80 | 470.88 | |
| Fixed Assets Annual | 204.41 | 195.22 | 187.62 | 161.05 | 173.74 | |
| Total Non Current Assets Annual | 365.38 | 359.78 | 337.64 | 307.66 | 318.63 | |
| Total Current Assets Annual | 278.50 | 272.94 | 270.02 | 238.14 | 152.25 | |
| Total Assets Annual | 643.88 | 632.72 | 607.66 | 545.80 | 470.88 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 404.97 | 156.92 | 129.81 | 234.87 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 167.64 | 129.31 | 113.41 | 116.03 | 167.88 | |
| Cash from Investing Activity Annual | -91.29 | -38.99 | -23.57 | -50.23 | 0.95 | |
| Cash from Financing Annual Activity | -84.80 | -86.18 | -89.41 | -61.56 | -164.78 | |
| Net Cash Flow Annual | - | 4.14 | 0.43 | 4.24 | 4.05 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 99.65 | 101.12 | 99.54 | 80.81 | 69.39 | |
| ROE Annual % | 13.43 | 12.04 | 33.45 | 26.48 | 24.11 | |
| ROCE Annual % | 18.03 | 16.15 | 42.39 | 34.03 | 38.11 | |
| Total Debt to Total Equity Annual | 0.04 | 0.00 | 0.00 | 0.00 | 0.01 | |
| EBDIT Annual Margin % | 25.66 | 24.39 | 44.85 | 37.13 | 41.50 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Icici Prudential India Opportunities Fund | 4.98 | 74796243 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Docon Technologies Private Limited | 71.11 | 74796238 | 100 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund | 7.3 | 74796242 |
| Icici Prudential India Opportunities Fund | 4.98 | 74796243 |
| Theleme India Master Fund Limited | 1.41 | 74796248 |
| Name | Holding Percent | Holding Id |
|---|
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Apr 20, 2023 | 18 | INTERIM | Apr 20, 2023 | Equity Share |
| May 11, 2022 | 15 | FINAL | May 12, 2022 | Equity Share |
| Jun 17, 2021 | 15 | FINAL | - | Equity Share |
| Nov 12, 2020 | 10 | INTERIM | Nov 13, 2020 | Equity Share |
| Nov 21, 2019 | 5 | INTERIM | Nov 22, 2019 | Equity Share |
| Aug 14, 2019 | 20 | FINAL | - | Equity Share |
| Aug 02, 2018 | 5 | FINAL | - | Equity Share |
| Feb 15, 2018 | 5 | INTERIM | Feb 16, 2018 | Equity Share |
| Aug 03, 2017 | 5 | FINAL | - | Equity Share |
| Feb 08, 2017 | 5 | INTERIM | Feb 09, 2017 | Equity Share |
| Sep 01, 2016 | 2.5 | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 14, 2024 | Audited Results & Final Dividend | - |
| Feb 01, 2024 | Quarterly Results | - |
| Oct 31, 2023 | Quarterly Results | - |
| Aug 01, 2023 | Quarterly Results | - |
| May 23, 2023 | Audited Results | - |
| Apr 07, 2023 | Interim Dividend | - |
| Feb 03, 2023 | Quarterly Results | - |
| Nov 11, 2022 | Quarterly Results | - |
| Aug 01, 2022 | Quarterly Results | - |
| Apr 29, 2022 | Audited Results & Dividend | - |
| Feb 12, 2022 | Quarterly Results | - |
| Nov 13, 2021 | Quarterly Results | - |
| Aug 12, 2021 | Quarterly Results | - |
| May 08, 2021 | Audited Results & Final Dividend | - |
| Jan 30, 2021 | Quarterly Results & 2nd Interim Dividend | - |
| Oct 28, 2020 | Quarterly Results & Interim Dividend | - |
| Sep 10, 2020 | Others | - |
| Jul 31, 2020 | Quarterly Results & Interim Dividend | - |
| May 23, 2020 | Audited Results, Final Dividend & ESOP | - |
| Feb 01, 2020 | Quarterly Results & Interim Dividend | - |
| Nov 07, 2019 | Quarterly Results & Interim Dividend | - |
| Aug 10, 2019 | Quarterly Results | - |
| Jun 13, 2019 | Others | inter alia, to discuss about the offer made by Dr. A. Velumani, Chairman, Managing Director & CEO to acquire the shareholding of the Company in Nueclear Healthcare Limited (NHL), the WoS of the Co. |
| May 18, 2019 | Audited Results, Dividend & ESOP | - |
| Feb 09, 2019 | Quarterly Results & Interim Dividend | - |
| Nov 03, 2018 | Quarterly Results | - |
| Aug 11, 2018 | Quarterly Results | - |
| Aug 04, 2018 | Buy Back of Shares | - |
| Apr 28, 2018 | Audited Results & Final Dividend | - |
| Feb 03, 2018 | Quarterly Results & Interim Dividend | - |
| Dec 09, 2017 | Quarterly Results & Interim Dividend | - |
| Aug 12, 2017 | Quarterly Results | - |
| May 09, 2017 | Audited Results, Dividend & ESOP | - |
| Mar 24, 2017 | Others | Reappointed Dr. A Velumani as Managing Director & CEO for period of three Years. |
| Jan 28, 2017 | Quarterly Results & Interim Dividend | - |
| Oct 24, 2016 | Quarterly Results | - |
| Aug 27, 2016 | General | - |
| Jul 22, 2016 | Quarterly Results | - |
| Jun 11, 2016 | Audited Results & Final Dividend | Granting of Employee Stock Options for the financial year ended March 31, 2016. |
| Ex-Date | Bonus Ratio | Record Date |
|---|
02 Jul 2024
Thyrocare Technologies Ltd - 539871 - Execution Of Business Transfer Agreement With Polo Labs Private Limited
Execution of Business Transfer Agreement with Polo Labs Private Limited
25 Jun 2024
Thyrocare Technologies Ltd - 539871 - Closure of Trading Window
Trading window closure intimation
25 Jun 2024
Thyrocare Technologies Ltd - 539871 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June 24, 2024 for Docon Technologies Pvt Ltd
24 Jun 2024
Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 24, 2024 for Docon Technologies Pvt Ltd
12 Jun 2024
Thyrocare Technologies Ltd - 539871 - Updates
Clarification in reference to the filing of Disclosure under SEBI (Prohibition of Insider Trading) Regulations 2015.
10 Jun 2024
Thyrocare Technologies Ltd - 539871 - Updates
Clarification in reference to the filing of Disclosure under the SEBI (Prohibition of Insider Trading) Regulations, 2015
08 Jun 2024
Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of copy of newspaper advertisement notice to equity shareholders regarding unclaimed equity shares due for transfer to IEPF.
28 May 2024
Thyrocare Technologies Ltd - 539871 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of the Listing Regulation read with SEBI circular no CIR/CFD/CMD1/27/2019, please find the enclosed herewith Annual Secretarial compliance report for the FY 2024.
17 May 2024
Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of earning calls for the quarter and year ended March 31, 2024
16 May 2024
Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement - Disclosure under Regulation 30 and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
